UNPRECEDENTED CAPABILITIES

The ACTIVATED COLLAGEN in CellerateRX® Powder and Gel is changing collagen's role in the art of advanced wound care.

CellerateRX's® patented collagen fragments (CRXa) are a fraction of the size of the native collagen molecules and particles found in other products, delivering the benefits of collagen to the body immediately.

CRXa helps jump start collagen's role in wound bed processes and enables CellerateRX® products to exceed the expectations of both clinicians and patients through all phases of wound healing.

UNPRECEDENTED BENEFITS

Unprecedented Range of Use:

• Frontline therapy, from first dressing to closure.
• Compatible with known single-objective therapies, including: silvers, debriders, grafts, and skin substitutes.

Unprecedented Patient Friendliness:

• Collagen occludes nerve endings to reduce pain.
• Ease of application increases patient compliance and provides minimal lifestyle interruption.
• Collagen minimizes potential of scarring.

PRODUCT FEATURES

CellerateRX® is available in two forms—powder that contains approximately 95% collagen, and gel that contains approximately 65% collagen. Both form an occlusive barrier and are effective in all wound phases.

Gel

• Donates moisture, forms occlusive barrier.
• Maintains moist environment and promotes autolytic debridement.
• Biodegradable and synthetic free. Does not require removal from wound site.
• Effective in all wound phases/states: inflamation, proliferation, maturation/necrotic, infected, granulating, remodeling.

Powder

• Mixes with wound exudates, absorbing up to 30x its own weight. Forms occlusive barrier.
• Mixes with exudates and promotes autolytic debridement.
• Biodegradable and synthetic free. Does not require removal from wound site.
• Effective in all wound phases/states: inflamation, proliferation, maturation/necrotic, infected, granulating, remodeling.

CHRONOLOGY OF WOUND HEALING

PRODUCT SELECTION

When to Use Powder, Gel, or a Combination:

• Powder: Moderate to heavily exudative wounds. The powder will absorb up to 30x its own weight, approximately 95% Type 1 collagen.
• Powder/Gel Combination: Transition from powder to gel when the exudates are better controlled, yet the higher percentage of collagen is still desired.the
• Gel: Light to moderately exudative wounds. The Gel will donate moisture to the wound site, approximately 65% Type 1 collagen.

Indications:

Averages 1/100th the Size of Native Collagen

CRX fragments average 1/100th the average size of intact native collagen molecules.

APPLICATION PROTOCOL

Initial Application: Debride wound. Powder: Completely cover moist wound bed with CellerateRX® powder. Gel: Apply generously to wound bed. Cover gel or powder with a non-stick type dressing appropriate for level of drainage.

Reapplication: CellerateRX® does not need to be debrided from the wound site. CellerateRX® may encourage the formation of a tan gelatinous cover, which is biodegradable and need not be removed. Re-apply CellerateRX® 3 times per week or with each dressing change.

*Store at controlled room temperature and protect from freezing.
**Contraindications: Known sensitivities to bovine or collagen products.